Search
for

    Sort by

    Research 331–360 of 1000+

    1. Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines European Journal of Pharmacology · 2022 · 1 citations
    2. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    3. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration Hormones · 2013 · 11 citations
    4. GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity Obesity Facts · 2025 · 3 citations
    5. Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh PLOS Global Public Health · 2025
    6. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity Vaccines · 2023
    7. Effectiveness of micronutrient rich supplement on the symptoms of polycystic ovarian syndrome among reproductive age women International Journal of Health Sciences (IJHS) · 2022
    8. Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis Evidence-based Complementary and Alternative Medicine · 2020 · 8 citations
    9. Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing IntechOpen eBooks · 2023 · 1 citations
    10. Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study Frontiers in Pharmacology · 2026
    11. Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen Frontiers in oncology · 2023
    12. Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study Frontiers in Pharmacology · 2024 · 1 citations
    13. Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation PLoS ONE · 2026
    14. 8273 ACTH-Dependent Cushing's Syndrome due to Metastatic Cervical Cancer: A Case Report Journal of the Endocrine Society · 2024
    15. 8273 ACTH-Dependent Cushing's Syndrome Due To Metastatic Cervical Cancer: A Case Report Journal of the Endocrine Society · 2024
    16. Evaluation of the CNC® prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study BMC women's health · 2022
    17. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    18. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer International Journal of Molecular Sciences · 2020 · 45 citations
    19. Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells Frontiers in Pharmacology · 2025
    20. Metabolic, Behavioral, and Reproductive Effects of Vertical Sleeve Gastrectomy in an Obese Rat Model of Polycystic Ovary Syndrome Obesity surgery · 2014 · 16 citations
    21. Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age BMC Women's Health · 2022 · 4 citations
    22. What’s new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women. PubMed · 2011
    23. Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231 BMC Pharmacology and Toxicology · 2013 · 68 citations
    24. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation Frontiers in Immunology · 2024 · 18 citations
    25. Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial The Oncologist · 2024 · 9 citations
    26. Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy Journal of Translational Medicine · 2025 · 8 citations
    27. Peer Review #4 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    28. Peer Review #1 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    29. Peer Review #2 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    30. Peer Review #4 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.2)" 2023